A clinical study to evaluate the efficacy of Madhuyashti granules and Shirodhara in the management of Attention Deficit Hyperactivity Disorder (ADHD) in school going children

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity and impulsivity. The growing prevalence of ADHD among school-going children necessitates exploring holistic and integrative treatment approaches. Ayurveda, with its personalized therapeutic interventions, offers a promising avenue for managing ADHD. This clinical study is aimed to evaluate the efficacy of Madhuyashti granules (Glycyrrhiza glabra) and Shirodhara (a classical Ayurvedic therapy) in managing ADHD symptoms in school-going children. A randomized, controlled clinical trial was conducted involving school-going children aged 6-15 years diagnosed with ADHD based on DSM V criteria. Participants were divided into two groups: Group A received Madhuyashti Granules (internally administered) only, while Group B received Madhuyashti Granules (internally administered) alongside Shirodhara therapy. The intervention was administered for 45 days. The primary outcomes were measured using qualitative parent-teacher feedback. Group B exhibited significant improvement in attention span, impulse control and hyperactivity compared to Group A. Madhuyashti Granules, known for their Medhya (nootropic) properties, enhanced cognitive functions, while Shirodhara provided calming effects, reducing hyperactivity and promoting focus. The integrative approach showed no adverse effects, demonstrating safety and efficacy. The combination of Madhuyashti Granules and Shirodhara proved effective in managing ADHD symptoms, offering a natural and holistic alternative for school-going children. Further large-scale studies are recommended to validate these findings and explore long-term benefits.